Cardiac Surgery News and Research

RSS

Multi-center study finds causes for neonatal mortality in infants with HLHS

A first-of-its-kind study led by Texas Children's Hospital and Baylor College of Medicine, published online in the journal, Circulation, found that infants with hypoplastic left heart syndrome born far from a hospital providing neonatal cardiac surgery for HLHS have increased neonatal mortality, with most deaths occurring before surgery.

24 Oct 2013

Elderly patients who have diabetes are more likely to suffer from postoperative delirium, undergo longer surgery

Elderly surgical patients are more likely to suffer from debilitating post-operative delirium if they have diabetes, undergo longer surgery or respond poorly to stress, according to a study presented at the ANESTHESIOLOGY™ 2013 annual meeting.

15 Oct 2013

Pregabalin drug can help reduce incidence of chronic pain following cardiac surgery

The incidence of chronic pain following cardiac surgery can be reduced in patients when the drug pregabalin is used before surgery and for 14 days post-surgery, according to a study presented at the ANESTHESIOLOGY 2013 annual meeting.

14 Oct 2013

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Northwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery.

10 Oct 2013

Team Ritter to raise funds for John Ritter Foundation for Aortic Health at ING NYC Marathon

Friends and family members of people with thoracic aortic disease and fans of the late legendary comedic actor John Ritter will come together as Team Ritter to raise funds for the John Ritter Foundation for Aortic Health at the ING New York City Marathon on Nov. 3, 2013.

10 Oct 2013

Lone atrial fibrillation in children has substantial symptomatic burden, recurrence rate

Atrial fibrillation (AF), characterized by a rapid and irregular heartbeat, is the most common chronic arrhythmia in adults, but is rare in children. In one of the first studies of pediatric "lone AF" (AF without associated heart disease), researchers found a nearly 40% recurrence rate and that AF in the young is accompanied by substantial symptoms.

8 Oct 2013

New medications may be used to treat common heart-rhythm problem

An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.

8 Oct 2013

Researchers discover new procedure for treatment of uterine fibroids

Jersey Shore University Medical Center announces today that Mark Martens, M.D., chief of Obstetrics and Gynecology, performed the first Acessa procedure in New Jersey. The procedure is used for the treatment of uterine fibroids. Additionally, Jersey Shore's Jocelyn A. Carlo, M.D., Obstetrics/Gynecology, is performing the procedure.

1 Oct 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

Cadence Health awarded grant to establish McCormick Foundation Simulation Training Center

Cadence Health today announced the Robert R. McCormick Foundation has awarded the system a $1 million grant to establish the McCormick Foundation Simulation Training Center at Central DuPage Hospital. The Simulation Training Center is scheduled to open later this year.

27 Sep 2013

Japanese MHLW approves Hizentra for treatment of primary and secondary immunodeficiencies

CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.

27 Sep 2013

Vera and Paul Guerin Family Congenital Heart Program to be established in Cedars-Sinai Heart Institute

In an effort to lengthen the life span and improve the quality of life for those born with heart defects, longtime Cedars-Sinai supporters Vera and Paul Guerin have donated $10 million to establish the Vera and Paul Guerin Family Congenital Heart Program in the Cedars-Sinai Heart Institute.

20 Sep 2013

Jersey Shore University Medical Center doctors receive volunteer faculty awards from Rutgers RWJMS

Jersey Shore University Medical Center physicians Glenn S. Parker, M.D., FACS, interim chief of Surgery; Stacy Doumas, M.D., Psychiatry; and Meghan Rattigan, D.O., Obstetrics and Gynecology, recently received volunteer faculty awards from Rutgers Robert Wood Johnson Medical School.

11 Sep 2013

Anti-thrombotic therapy interruption has no influence on perioperative complications in cardiac patients

A shortened pre-surgical interruption of anti-thrombotic therapy, compared to the more traditional one-week interruption, has no influence on perioperative complications in cardiac patients, according to the results of the PRAGUE 14 trial.

5 Sep 2013

TAVI is safe therapeutic option than redo cardiac surgery

Use of bioprosthetic heart valves has dramatically increased (from 18% in 1991 to 59% in 2003), mainly in older patients with comorbidities. This is due to the increased risk of bleeding complications associated with lifelong use of anticoagulation for mechanical prostheses.

2 Sep 2013

AACN offers online educational support for cardiac nurses

Nurses caring for acutely or critically ill cardiovascular patients can take heart: The American Association of Critical-Care Nurses offers online educational support for cardiac nurses interested in deepening their expertise and acquiring subspecialty certification.

28 Aug 2013

Jersey Shore receives accreditation from BSCN for providing high quality care

Jersey Shore University Medical Center's bariatric surgery program has been accredited as a Level 2 facility under the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS). The accreditation demonstrates the hospital's commitment to providing the highest quality care for bariatric surgery patients.

21 Aug 2013

Keeping NYC hospitals open becomes new issue in mayoral race

NYC's hospitals have become a big issue in the city's mayoral race. In the meantime, New York state health officials have posted a plethora of data online about the state's hospitals and doctors.

21 Aug 2013

BioVentrix uses Revivent system for LIVE procedure in Germany

BioVentrix, a pioneer of technologies and procedures for the less-invasive treatment of heart failure (HF), today announced the successful first-use of its Revivent™ Myocardial Anchoring System, via Less Invasive Ventricular Enhancement™ or the LIVE™ procedure in Germany.

13 Aug 2013

Meridian Health earns Chest Pain Center Accreditation

Meridian Health, a leading New Jersey health care system, has recently earned the highest designated Chest Pain Center Accreditation by the Society of Cardiovascular Patient Care, a global not-for-profit organization committed to leading the fight to eliminate heart disease as the number one cause of death worldwide.

6 Aug 2013